128 related articles for article (PubMed ID: 15067734)
1. [Effect of fragile histidine triad gene on apoptosis of MGC-803 gastric cancer cells].
Kong M; Chen WZ; Chen Z; Li MW
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 33(2):133-7. PubMed ID: 15067734
[TBL] [Abstract][Full Text] [Related]
2. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.
Sard L; Accornero P; Tornielli S; Delia D; Bunone G; Campiglio M; Colombo MP; Gramegna M; Croce CM; Pierotti MA; Sozzi G
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8489-92. PubMed ID: 10411902
[TBL] [Abstract][Full Text] [Related]
3. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
[TBL] [Abstract][Full Text] [Related]
4. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
[TBL] [Abstract][Full Text] [Related]
5. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
6. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
[TBL] [Abstract][Full Text] [Related]
7. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
Song X; Tian Z; Wang S; Peng Z; Feng J
Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
[TBL] [Abstract][Full Text] [Related]
8. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
[TBL] [Abstract][Full Text] [Related]
9. Effect of FHIT gene replacement on growth, cell cycle and apoptosis in pancreatic cancer cells.
Gopalakrishnan VK; Banerjee AG; Vishwanatha JK
Pancreatology; 2003; 3(4):293-302. PubMed ID: 12890991
[TBL] [Abstract][Full Text] [Related]
10. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
Wu R; Connolly DC; Dunn RL; Cho KR
J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
[TBL] [Abstract][Full Text] [Related]
12. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
13. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
14. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
Liu F; Wu JZ; Li F; Li Y; Li J
Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
[TBL] [Abstract][Full Text] [Related]
15. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
Lee SH; Kim HS
Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
[TBL] [Abstract][Full Text] [Related]
17. [The inhibition of fragile histidine triad gene on the proliferation and tumorigenicity of mucoepidermoid carcinoma cells].
Liu F; Wu JZ; Li F; Li Y; Li J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):252-5. PubMed ID: 18705504
[TBL] [Abstract][Full Text] [Related]
18. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
20. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype.
Kawaguchi K; Yashima K; Koda M; Tsutsumi A; Kitaoka S; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Murawaki Y
Br J Cancer; 2004 Feb; 90(3):672-7. PubMed ID: 14760383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]